Search

everythinglearnresearchcommunity

for

Search:↓

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

PRP shows promise for hair growth but needs standardized methods for better results.

Accurate testosterone measurement and standardized lab practices are crucial for diagnosing and managing adult male hypogonadism.

Standardized kits improve the quality and consistency of isolating stem cells from fat tissue.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Male pattern baldness worsens with age and can be treated with medications like minoxidil and finasteride, but side effects and personalized care are important.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

The WRAHPS Guidelines standardize reporting in wound healing studies to improve research quality and therapy development.

PRP is a promising and safe treatment for early to moderate knee osteoarthritis but needs standardized protocols.

PCOS affects 11% of women, highlighting the need for standardized diagnosis.

Plant-derived nanovesicles show promise in cancer treatment but need standardized preparation.

Hair loss affects attractiveness but can suggest intelligence, and face perception is complex, involving factors like age and smile.

Certain medications, especially nervous system drugs, can cause insomnia, with risks varying by age and gender.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Men in the U.S. have more health issues, higher death rates from various diseases, lower life expectancy, and are less likely to seek healthcare.

Improved collaboration and education between dermatologists and oncologists can enhance care for chemotherapy-related hair loss.

Nanotechnology could improve hair loss treatments by delivering drugs more effectively.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Adults with alopecia areata often have empty follicular openings, while children show more honeycomb pigment patterns.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

COVID-19 affects multiple body systems, not just the lungs.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

Oral minoxidil effectively improves hair regrowth in cancer survivors with late alopecia.

Lower testosterone levels increase kidney stone risk in men over 40.

An alternating inflatable head pad reduced pressure ulcers and hair loss in heart surgery patients.

Traditional Chinese medicine may help relieve symptoms of Cronkhite-Canada syndrome.

LED therapy can safely and effectively regrow eyebrows in people with frontal fibrosing alopecia.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.